Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Proteomic Identification of Plasma Biomarkers of Response to IL‐5 Inhibitor Biologics in Healthy Subjects

Clinical and Translational Science(2025)10.1111/cts.70412Source: DataRank Database

Proteomic Identification of Plasma Biomarkers of Response to IL‐5 Inhibitor Biologics in Healthy Subjects is a research paper published in Clinical and Translational Science (2025). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

Linked data & code

uniprot nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 0.00)OA: goldTopics (41)IDs (PubMed, PMC, OpenAlex)Annotations (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (15)

Deepti Pranay Samarth ORCID,Kristina E. Howard ORCID,Yan Guo ORCID,Esraa G. Mohamed,Erica Decker ORCID

Live enrichment

PubMed:41319239 PMC:PMC12665252 OpenAlex:https://openalex.org/W4416828778

U.S. Food and Drug Administration

FWCI

0.00

Citation Percentile

0.2%

goldLicense: cc-by-nc-nd

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/cts.70412

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/cts.70412

publisherhttps://ascpt.onlinelibrary.wiley.com/doi/pdf/10.1111/cts.70412

journalhttps://doi.org/10.1111/cts.70412

repositoryhttps://pubmed.ncbi.nlm.nih.gov/41319239

Fields of Study

Advanced Proteomics Techniques and ApplicationsAdvanced Biosensing Techniques and ApplicationsAsthma and respiratory diseasesHumansInterleukin-5Antibodies, Monoclonal, HumanizedProteomicsBiomarkersMaleHealthy VolunteersAdultFemaleYoung AdultDose-Response Relationship, DrugMiddle AgedLongitudinal StudiesDouble-Blind Method

MeSH Terms

AdultDose-Response Relationship, DrugDouble-Blind MethodFemaleHumansLongitudinal StudiesMaleMiddle AgedBiomarkersInterleukin-5ProteomicsYoung AdultAntibodies, Monoclonal, HumanizedHealthy Volunteers

Keywords

MepolizumabPlaceboBiomarkerProteomicsArea under the curveDrugInhibitorsBiomarkersPharmacodynamic BiomarkersInterleukin‐5

Proteomic Identification of Plasma Biomarkers of Response to IL‐5 Inhibitor Biologics in Healthy Subjects

FAIR Checklist

Authors (15)

Funding (2 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)